Fletta eftir höfundi "Gunnarsdóttir, Anna Ingibjörg"

Atriði 1-2 af 2

Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible

Palsson, Olafur; Löve, Þorvarður Jón; Gunnarsdóttir, Anna Ingibjörg; Gunnarsson, Pétur Sigurður; Rúnarsdóttir, Eydís Erla; Krogh, Niels Steen; Gudbjornsson, Bjorn (BMJ, 2019-07)

Objectives To determine in a retrospective cohort whether patients with psoriatic arthritis (PsA) who would not have fulfilled the inclusion criteria for randomised controlled trials (RCTs) for the TNF inhibitor (TNFi) chosen for their treatment (excl) ...
A patients’ perspective towards the injection devices for Humira® and Imraldi® in a Nationwide witching program

Karlsdóttir, Kristín; Gunnarsdóttir, Anna Ingibjörg; Gröndal, Gerður María; Löve, Þorvarður Jón; Stefánsdóttir, Elínborg; Davíðsdóttir, Lóa Guðrún; Thorleifsdottir, Ragna H.; Guðbjörnsson, Björn (2022-01-27)

Objective: Due to a tender process in Iceland, all patients on Humira® were switched nationwide to its biosimilar Imraldi® in March 2019. The study aimed to explore the patient's perspective of the Humira® and Imraldi® injection devices. Methods: A ...

Atriði 1-2 af 2

Leita